Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: A preliminary report
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 39 (3) , 249-252
- https://doi.org/10.1016/0090-8258(90)90246-h
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary reportGynecologic Oncology, 1989
- Chemotherapy Consisting of Cisplatin, Doxorubicin, and Cyclophosphamide as an Adjunct to Surgery in Stage Ic-II Epithelial Ovarian CarcinomaAmerican Journal of Clinical Oncology, 1989
- The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.Journal of Clinical Oncology, 1988
- Initial therapy for early ovarian carcinomaCancer, 1987
- Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.Journal of Clinical Oncology, 1987
- Ovarian cancer in the elderly: An analysis of Surveillance, Epidemiology, and End Results Program dataAmerican Journal of Obstetrics and Gynecology, 1986
- Stage II invasive adenocarcinoma of the ovary: Results of treatment by whole abdominal radiation plus pelvic boost versus pelvic radiation plus oral melphalan chemotherapyGynecologic Oncology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958